{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:33:30Z","timestamp":1784194410640,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1989,7,1]],"date-time":"1989-07-01T00:00:00Z","timestamp":615254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1989,7]]},"DOI":"10.1007\/bf01639528","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T01:25:27Z","timestamp":1115429127000},"page":"240-244","source":"Crossref","is-referenced-by-count":25,"title":["Prevention of bacteremia caused by \u03b1-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin","Roxithromycin (RU-28 965) zur Pr\u00e4vention der Bakteri\u00e4mie durch alpha-h\u00e4molytische Streptokokken bei granulozytopenischen Patienten unter Ciprofloxacin-Prophylaxe"],"prefix":"10.1007","volume":"17","author":[{"given":"Maja","family":"Rozenberg-Arska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Verdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-77-5-707","volume":"77","author":"S. C. Schimpff","year":"1972","unstructured":"Schimpff, S. C., Young, V. M., Greene, W. H., Vermeulen, G. D., Moody, M. R., Wiernik, P. H. Origin of infection in acute nonlymphocytic leukemia: significance of hospital acquisition of potential pathogens. Ann. Intern. Med. 77 (1972) 707\u201314.","journal-title":"Ann. Intern. Med."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0014-2964(80)90140-1","volume":"16","author":"D. T. Sleijfer","year":"1980","unstructured":"Sleijfer, D. T., Mulder, N. H., De Vries-Hospers, H. G., Fidler, V., Nieweg, H. O., Van der Waaji, D., Van Saene, H. K. F. Infection prevention in granulocytopenic patients by selective decontamination of the gastrointestinal tract. Eur. J. Cancer 16 (1980) 859\u2013869.","journal-title":"Eur. J. Cancer"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-95-5-555","volume":"95","author":"A. W. Dekker","year":"1981","unstructured":"Dekker, A. W., Rozenberg-Arska, M., Sixma, J. J., Verhoef, J. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia. Ann. Intern. Med. 95 (1981) 555\u2013559.","journal-title":"Ann. Intern. Med."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0002-9343(83)91017-3","volume":"74","author":"C. A. Kaufman","year":"1983","unstructured":"Kaufman, C. A., Liepman, M. K., Bergman A. G., Mioduszewski, J. Trimethoprim\/sulfamethoxazole prophylaxis in neutropenic patients: reduction of infections and effect on bacterial and fungal flora. Am. J. Med. 74 (1983) 599\u2013607.","journal-title":"Am. J. Med."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/infdis\/147.4.611","volume":"147","author":"L. S. Young","year":"1983","unstructured":"Young, L. S. Antimicrobial prophylaxis against infection in neutropenic patients. J. Infect. Dis. 147 (1983) 611\u2013614.","journal-title":"J. Infect. Dis."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-106-1-7","volume":"106","author":"A. W. Dekker","year":"1987","unstructured":"Dekker, A. W., Rozenberg-Arska, M., Verhoef, J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann. Intern. Med. 106 (1987) 7\u201312.","journal-title":"Ann. Intern. Med."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0002-9343(86)90633-9","volume":"80","author":"D. J. Winston","year":"1986","unstructured":"Winston, D. J., Ho, W. G., Nakao, S. L., Gale, R. P, Champlin, R. E. Norfloxacin versus vancomycin\/polymyxin for prevention of infections in granulocytopenic patients. Am. J. Med. 80 (1986) 884\u2013889.","journal-title":"Am. J. Med."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-106-1-1","volume":"106","author":"J., E. Karp","year":"1987","unstructured":"Karp, J., E., Merz, W.G., Hendricksen, C., Laughon, B., Redden T., Bamberger, B. J., Bartlett, J. G., Saral, R., Burke, P. J. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double blind, placebo-controlled trial. Ann. Intern. Med. 106 (1987) 1\u20137.","journal-title":"Ann. Intern. Med."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/infdis\/152.1.104","volume":"153","author":"M. Rozenberg-Arska","year":"1985","unstructured":"Rozenberg-Arska, M., Dekker, A. W., Verhoef, J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J. Infect. Dis. 153 (1985) 104\u2013107.","journal-title":"J. Infect. Dis."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0140-6736(83)90799-7","volume":"II","author":"J. Cohen","year":"1983","unstructured":"Cohen, J., Donnelly, J. P., Worsley, A. M., Catovsky, D., Goldman, J. M., Galton, D. A. G. Septicemia caused by viridans streptococci in neutropenic patients with leukemia. Lancet II (1983) 1452\u20131454.","journal-title":"Lancet"},{"key":"CR11","first-page":"333","volume-title":"Hematology and blood transfusion. Acute leukemias, vol. 30","author":"A. W. Dekker","year":"1987","unstructured":"Dekker, A. W., Punt, K., Verdonck, L. F. The use of amsacrine plus intermediate-dose cytosine arabinoside in relapsed and refractory acute nonlymphocytic leukemia. In:B\u00fcchner, T., Schellong, G., Hiddemann, W., Urabnitz, D., Ritter, J. (eds): Hematology and blood transfusion. Acute leukemias, vol. 30. Springer-Verlag, Berlin, Heidelberg 1987, pp. 333\u2013335."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0609.1988.tb00824.x","volume":"40","author":"W. G. Peters","year":"1988","unstructured":"Peters, W. G., Wilemze, R., Colly, L. P. Results of induction and consolidation treatment with intermediate and high-dose cytosine arabinoside and m-Amsa of patients with poor-risk acute myelogenous leukemia. Eur. J. Hematol. 40 (1988) 198\u2013204.","journal-title":"Eur. J. Hematol."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","volume":"315","author":"P. A. Pizzo","year":"1988","unstructured":"Pizzo, P. A., Hathorn, J. W., Hiemez, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longs, D., Marshal, D., McKnight, J., Rubin, M., Skelton, J., Tahler, M., Wesley, R. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N. Engl. J. Med. 315 (1988) 552\u2013558.","journal-title":"N. Engl. J. Med."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(84)90440-9","volume":"I","author":"J. Henslee","year":"1984","unstructured":"Henslee, J., Bostrom, B., Weidsdorf, D., Ramsay, N., McGlave, P., Kersey, J. Streptococcal sepsis in bone marrow transplant patients. Lancet (Letter) I (1984) 393.","journal-title":"Lancet"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/BF01743253","volume":"65","author":"W. Kern","year":"1987","unstructured":"Kern, W., Kurrle, E., Vanek, E. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klin. Wochenschr. 65 (1987) 773\u2013780.","journal-title":"Klin. Wochenschr."},{"key":"CR16","unstructured":"Steiner, M. Villablanca, J., Kersey, J., Ramsay, N., Ferrier, M., Haake, R., Weisdorf, D.: \u03b1-streptococcal shock in bone marrow transplantation patients. Blood 72 (1988), suppl. 1. 30th Annual Meeting of the American Society of Hematology, San Antonio, December 3\u20136, 1988. Abstract 1548."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/17.2.161","volume":"17","author":"K. V. Rolston","year":"1986","unstructured":"Rolston, K. V., Le Blanc, B., Ho, D. H. In vitro activity of RU 28965 a new macrolide compared to that of erythromycin. J. Antimicrob. Chemother. 17 (1986) 161\u2013163.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR18","first-page":"128","volume-title":"Macrolides: a review with an outlook on future developments","author":"S. L. Puri","year":"1986","unstructured":"Puri, S. L., Lassmann, H. B., Ho, J., Sabo, R., Barry, A. Safety, tolerance and pharmacokinetics of single and multiple oral doses of RU 28965 (a new macrolide antibiotic) in healthy men. In:Butzler, J. P., Kobayashi, H. (eds): Macrolides: a review with an outlook on future developments. Excerpta Medica, Geneva 1986, pp. 128\u2013173."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/AAC.22.5.743","volume":"22","author":"H. O. Hallander","year":"1982","unstructured":"Hallander, H. O., Dornsbusch, K., Gezelius, L., Jacobson, K., Karlsson, J. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve. Antimicrob. Agents Chemother. 22 (1982) 743\u2013752.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/AAC.25.1.142","volume":"25","author":"L. Verbist","year":"1984","unstructured":"Verbist, L., Verhaegen, J. M. Effect of temocillin in combination with other \u03b2-lactam antibiotics. Antimicrob. Agents Chemother. 25 (1984) 142\u2013144.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/infdis\/136.2.196","volume":"136","author":"C. W. Stratton","year":"1977","unstructured":"Stratton, C. W., Reller, L. B. Serum dilution test for bactericidal activity. II. Standardisation and correlation with antimicrobial assays and susceptibility test. J. Infect. Dis. 136 (1977) 196\u2013204.","journal-title":"J. Infect. Dis."},{"key":"CR22","doi-asserted-by":"crossref","unstructured":"Antibiotic Antagonism and Synergism (editorial). Lancet I (1978) 80\u201382.","DOI":"10.1016\/S0140-6736(78)91389-2"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01639528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01639528\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01639528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T07:44:49Z","timestamp":1586245489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01639528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,7]]}},"alternative-id":["BF01639528"],"URL":"https:\/\/doi.org\/10.1007\/bf01639528","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,7]]}}}